Projected Income Statement: K+S AG

Forecast Balance Sheet: K+S AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 3,016 1,124 -255 -123 -53.8 -19.3 -22.2 -97.8
Change - -62.73% -122.69% 51.76% 56.26% 64.13% -15.03% -340.54%
Announcement Date 3/11/21 3/10/22 3/15/23 3/14/24 3/13/25 - - -
1EUR in Million
Estimates

Cash Flow Forecast: K+S AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 500.5 343.6 356.3 470 522.1 546.8 567.9 519.6
Change - -31.35% 3.7% 31.91% 11.09% 4.72% 3.87% -8.51%
Free Cash Flow (FCF) 1 -72 -16.7 1,036 351 68.7 39.5 33 65.55
Change - 76.81% 6,301.2% -66.11% -80.43% -42.5% -16.46% 98.64%
Announcement Date 3/11/21 3/10/22 3/15/23 3/14/24 3/13/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: K+S AG

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 12.03% 30.16% 42.68% 18.4% 15.27% 16.48% 17.28% 16.86%
EBIT Margin (%) 1.03% 21.06% 34.77% 6.6% -0.06% -21.1% 6.14% 5.35%
EBT Margin (%) -54.05% 75.5% 37.61% 7.67% -2.97% -50.3% 7.23% 5.7%
Net margin (%) -46.37% 92.84% 26.57% 5.43% -1.83% -43.68% 4.43% 3.55%
FCF margin (%) -1.95% -0.52% 18.24% 9.06% 1.88% 1.08% 0.89% 1.74%
FCF / Net Income (%) 4.2% -0.56% 68.66% 166.98% -102.84% -2.47% 20.07% 49.15%

Profitability

        
ROA -18.07% 25.94% 16.21% 2.17% 0.2% -13.33% 2.15% 2.11%
ROE -51.08% 59.09% 25.18% 3.18% 0.1% -28.39% 3.6% 3.39%

Financial Health

        
Leverage (Debt/EBITDA) 6.78x 1.16x - - - - - -
Debt / Free cash flow -41.89x -67.31x - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 13.53% 10.69% 6.28% 12.14% 14.29% 14.93% 15.31% 13.82%
CAPEX / EBITDA (%) 112.52% 35.46% 14.71% 65.97% 93.62% 90.62% 88.59% 81.95%
CAPEX / FCF (%) -695.14% -2,057.49% 34.41% 133.9% 759.97% 1,384.19% 1,720.93% 792.64%

Items per share

        
Cash flow per share 1 3.343 1.708 7.272 4.383 3.299 3.336 3.125 3.338
Change - -48.91% 325.79% -39.72% -24.74% 1.13% -6.32% 6.8%
Dividend per Share 1 0.04 0.2 1 0.7 0.15 0.0905 0.084 0.1771
Change - 400% 400% -30% -78.57% -39.66% -7.15% 110.72%
Book Value Per Share 1 11.6 27.68 35.11 36.31 34.71 26.73 27.47 28.29
Change - 138.52% 26.86% 3.42% -4.41% -22.98% 2.76% 2.99%
EPS 1 -8.96 15.59 7.88 1.12 -0.37 -8.957 0.9394 0.7446
Change - 274% -49.45% -85.79% -133.04% -2,320.77% 110.49% -20.73%
Nbr of stocks (in thousands) 191,400 191,400 191,400 179,100 179,100 179,100 179,100 179,100
Announcement Date 3/11/21 3/10/22 3/15/23 3/14/24 3/13/25 - - -
1EUR
Estimates
2025 *2026 *
P/E ratio -1.45x 13.8x
PBR 0.48x 0.47x
EV / Sales 0.63x 0.62x
Yield 0.7% 0.65%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
12.95EUR
Average target price
12.10EUR
Spread / Average Target
-6.56%
Consensus

Quarterly revenue - Rate of surprise